- Home
- OWLT vs HURA Comparison
OWLT vs HURA Comparison
Compare OWLT & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OWLT | HURA |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.8M | 123.0M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | OWLT | HURA |
|---|---|---|
| Price | $4.53 | $1.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $13.00 | $8.04 |
| AVG Volume (30 Days) | 109.0K | ★ 366.5K |
| Earning Date | 11-16-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 47.93 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $105,708,000.00 | N/A |
| Revenue This Year | $13.29 | N/A |
| Revenue Next Year | $20.39 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 35.43 | N/A |
| 52 Week Low | $4.02 | $0.41 |
| 52 Week High | $16.94 | $3.43 |
Technical Indicators
Market Signals| Indicator | OWLT | HURA |
|---|---|---|
| Relative Strength Index (RSI) | 42.73 | 37.99 |
| Support Level | N/A | $1.27 |
| Resistance Level | $6.08 | $2.22 |
| Average True Range (ATR) | 0.19 | 0.19 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 42.00 | 0.86 |
Price Performance
Historical ComparisonAbout OWLT Owlet Inc.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.
About HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.